COVID-19 and reactions in the Norwegian population

Publications 2026

Gyawali S, Nakstad ER, Sletvold B, Lurås H, Wisløff T, Benth FE, Šaltytė Benth J (2026)
Infection dynamics across regions during the COVID-19 pandemic in Norway
J Infect Public Health, 19 (9), 103328 (in press)
DOI 10.1016/j.jiph.2026.103328, PubMed 42556187

Tritschler T, Fuster V, Lawler PR, Farkouh ME, Marx CE, Neal MD, Sholzberg M, Spyropoulos AC, Tong SYC, Muñoz-Rivas N, Blondon M, Berger JS, Bikdeli B, Cattaneo M, Cushman M, Goldin M, Goligher EC, Hochman JS, Jüni P, McQuilten ZK, Morici N, Sadeghipour P, Venkatesh B, Zuily S, Amstutz A et al. (2026)
Timing, Translation, and Preparedness: Lessons Learned From COVID-19 Anticoagulation in Noncritically Ill Hospitalized Patients
J Am Coll Cardiol, 88 (4), 437-450
DOI 10.1016/j.jacc.2026.05.028, PubMed 42523015

Oppegaard O, Blomberg B, Cox RJ, Iversen A, Myklebust NN, Glambek M, Tøndel C, Dahl TB, Friis T, Mjøs E, Lehmann ME, Sandvig A, Devold V, Wilhelmsen M, Trøseid M, Lie RT, Aukrust P, Langeland N, PANORAMIC Norway Working Group (2026)
Nirmatrelvir for acute COVID-19 to prevent long COVID (PANORAMIC Norway): a double-blind, randomised, placebo-controlled trial
Lancet Infect Dis (in press)
DOI 10.1016/S1473-3099(26)00244-6, PubMed 42462744